Bone growth stimulators sales will rise through 2036, driven by invasive electrical bone growth stimulators at 85.2% of the product segment in 2026, supported by increasing clinical adoption and expanding procedural volume. The market was valued at USD 2.50 billion in 2025 and is expected to be worth USD 6.78 billion by 2036.